BH

Bingsong Han

FT Forma Therapeutics: 35 patents #5 of 86Top 6%
VH Valo Health: 13 patents #4 of 53Top 8%
FT Forma Tm: 7 patents #5 of 24Top 25%
NE Neurogen: 7 patents #39 of 120Top 35%
Genentech: 7 patents #424 of 2,392Top 20%
VD Valo Early Discovery: 6 patents #7 of 30Top 25%
NA Novo Nordisk Health Care Ag: 3 patents #20 of 131Top 20%
NP Novartis International Pharmaceutical: 1 patents #29 of 55Top 55%
HI H. Lee Moffitt Cancer Center And Research Institute: 1 patents #146 of 269Top 55%
📍 Westwood, MA: #1 of 265 inventorsTop 1%
🗺 Massachusetts: #490 of 88,656 inventorsTop 1%
Overall (All Time): #26,124 of 4,157,543Top 1%
74
Patents All Time

Issued Patents All Time

Showing 26–50 of 74 patents

Patent #TitleCo-InventorsDate
10772874 Compounds and compositions for the inhibition of NAMPT Kenneth W. Bair, Timm R. Baumeister, Alexandre Joseph Buckmelter, Karl H. Clodfelter, Peter Dragovich +8 more 2020-09-15
10696692 Amido-benzyl sulfone and sulfoxide derivates Kenneth W. Bair, Timm R. Baumeister, Alexandre Joseph Buckmelter, Karl H. Clodfelter, Peter Dragovich +12 more 2020-06-30
10647695 Compounds and compositions for the inhibition of NAMPT Kenneth W. Bair, Timm R. Baumeister, Alexandre Joseph Buckmelter, Karl H. Clodfelter, Jian Lin +5 more 2020-05-12
10538496 Methods using HDAC11 inhibitors Jennifer Lee, Pearlie Burnette, Srikumar Chellappan, Nicholas Barczak, Jaime Escobedo +8 more 2020-01-21
10513501 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2019-12-24
10508088 Methods using HDAC11 inhibitors Jennifer Lee, Nicholas Barczak, Jaime Escobedo, Chiara Conti, David R. Lancia, Jr. +6 more 2019-12-17
10508077 Alpha-cinnamide compounds and compositions as HDAC8 inhibitors Kenneth W. Bair, Nicholas Barczak, David R. Lancia, Jr., Cuixian Liu, Matthew W. Martin +5 more 2019-12-17
10501424 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-12-10
10494354 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-12-03
10494353 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-12-03
10494352 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-12-03
10494351 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-12-03
10479772 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-11-19
10472337 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-11-12
10464909 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +6 more 2019-11-05
10464910 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +6 more 2019-11-05
10456382 Compounds and compositions for the inhibition of NAMPT Kenneth W. Bair, Timm R. Baumeister, Alexandre Joseph Buckmelter, Karl H. Clodfelter, Peter Dragovich +8 more 2019-10-29
10457652 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +6 more 2019-10-29
10450284 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-10-22
10450283 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2019-10-22
10442776 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +6 more 2019-10-15
10428031 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2019-10-01
10421732 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +6 more 2019-09-24
10421731 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2019-09-24
10414738 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2019-09-17